HomeBusinessHealthcareDaxor (DXR) CEO On Blood Volume Testing
Daxor (DXR) CEO On Blood Volume Testing

The CEO of Daxor (DXR) Michael Feldschuh talks about his company, shares of which began trading on the Nasdaq Wednesday, Feb. 2, 2022. Founded in 1971, Daxor is a global leader in blood volume measurement technology and specializes in blood volume testing, which is pivotal to the healthcare industry. The company has a market cap of $45.28M and manufactures the first diagnostic blood test that has been cleared by the FDA

Market On Close

03 Feb 2022

ON AIR
6:00 am
Fast Market
replay
12:00 am
Fast Market
REPLAY
1:00 am
Trading 360
REPLAY
2:00 am
Next Gen Investing
REPLAY
education
3:00 am
Your First Trade
REPLAY
3:30 am
Trading 360
REPLAY
4:30 am
Next Gen Investing
REPLAY
education
5:30 am
Your First Trade
REPLAY
ON AIR
6:00 am
Fast Market
REPLAY
7:00 am
Futures
8:00 am
Morning Trade Live
10:00 am
Trading 360
11:00 am
Fast Market
12:00 pm
Next Gen Investing
1:00 pm
The Watch List
2:00 pm
Market On Close
education
3:30 pm
Your First Trade
4:00 pm
Trading 360
REPLAY
5:00 pm
Fast Market
REPLAY
6:00 pm
Next Gen Investing
REPLAY
education
7:00 pm
Your First Trade
REPLAY
7:30 pm
Trading 360
REPLAY
8:30 pm
Fast Market
REPLAY
9:30 pm
Next Gen Investing
REPLAY
education
10:30 pm
Your First Trade
REPLAY
11:00 pm
Trading 360
REPLAY

Get Market Minute

Daily insights for every investor

FOLLOW US